Institutions disagree (3 filers, 51% apart) — shown at its seed round, Sep 2025 ($1.4M post-money).
- ·44 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Upstream Biotechnology funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Seed Round | $625K | ▮ | ▮ |
Membership and data by Private Market View
Upstream Biotechnology valuation
Upstream Biotechnology is valued at approximately $1.4 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its seed round in Sep 2025, at a $1.4 million post-money valuation.
Recent activity
In the last 90 days, Upstream Biotechnology's record added 5 institutional fund marks (latest period Jul 2026).
How much has Upstream Biotechnology raised?
Upstream Biotechnology has raised $830,000 in total; 1 of its rounds is on record. The largest on record was a $625,000 seed round in Aug 2025.
Upstream Biotechnology has filed 1 Form D with the SEC, most recently in Sep 2025 ($625,000 sold to 3 investors).
Institutional holders and vehicles
4 SEC-registered funds reported 44 fair-value marks on Upstream Biotechnology between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Upstream Biotechnology's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Upstream Biotechnology, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Upstream Biotechnology
- What is Upstream Biotechnology worth?
- Upstream Biotechnology is valued at $1.4M as of Oct 2026. Institutions disagree (3 filers, 51% apart) — shown at its seed round, Sep 2025 ($1.4M post-money).
- How much has Upstream Biotechnology raised?
- Upstream Biotechnology has raised $830K in total funding across 1 recorded rounds.
- When did Upstream Biotechnology last raise?
- Upstream Biotechnology last raised in Aug 2025 (Seed Round), raising $625K.